Detalhe da pesquisa
1.
Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.
Cell
; 148(1-2): 362-75, 2012 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22265421
2.
Minorities Face Delays to Pancreatic Cancer Treatment Regardless of Diagnosis Setting.
Ann Surg Oncol
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789617
3.
Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design.
Future Oncol
; 20(8): 437-446, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38264869
4.
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.
Lancet Oncol
; 24(12): 1387-1398, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039992
5.
Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
Ann Surg
; 278(4): 598-608, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334719
6.
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.
Eur J Nucl Med Mol Imaging
; 50(2): 328-343, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114872
7.
Effectiveness of the nutrition referral system in a multidisciplinary pancreatic cancer clinic.
Support Care Cancer
; 31(6): 322, 2023 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148382
8.
Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
Ann Surg
; 276(3): 450-462, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972511
9.
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.
Ann Surg Oncol
; 29(1): 401-414, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448965
10.
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.
Ann Surg Oncol
; 29(4): 2456-2468, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129721
11.
Using patient flow analysis with real-time patient tracking to optimize radiation oncology consultation visits.
BMC Health Serv Res
; 22(1): 1517, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36514109
12.
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care.
J Natl Compr Canc Netw
; 19(7): 805-813, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878727
13.
EUS-guided hydrogel microparticle injection in a cadaveric model.
J Appl Clin Med Phys
; 22(6): 83-91, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028956
14.
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
Gastroenterology
; 156(1): 108-118.e4, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30240661
15.
Recent progress in pancreatic cancer.
CA Cancer J Clin
; 63(5): 318-48, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23856911
16.
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival.
BMC Cancer
; 19(1): 569, 2019 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31185957
17.
EUS-guided fiducial placement for GI malignancies: a systematic review and meta-analysis.
Gastrointest Endosc
; 89(4): 659-670.e18, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30445001
18.
Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment.
Qual Life Res
; 28(11): 2929-2939, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273624
19.
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
Cancer
; 124(8): 1701-1709, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370450
20.
Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer.
Ann Surg
; 267(3): 544-551, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787294